Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $4.54 Million - $5.62 Million
-35,000 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$119.87 - $145.67 $4.2 Million - $5.1 Million
35,000 New
35,000 $4.46 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $4.76 Million - $6.84 Million
-37,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $1.75 Million - $2.03 Million
10,900 Added 41.76%
37,000 $6.57 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $3.92 Million - $4.53 Million
26,100 New
26,100 $4.29 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.